EUVIMEDEUVIMED entdecken
Crossref

Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer

Taku Kato iD, Eiji Sugihara, Yuko Hata, Kyojiro Kawakami, Yasunori Fujita, Kosuke Mizutani, Tatsuya Ando, Yasuhiro Sakai, Kouhei Sakurai, Shohei Toyota, Hidetoshi Ehara, Masafumi Ito und 1 weitere

The Prostate · 2024

DOI: 10.1002/pros.24792 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Taku Kato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Japan. Hauptthemen laut MEDLINE: Extracellular Vesicles, RNA, Messenger, Prostatic Neoplasms, Castration-Resistant, Succinate Dehydrogenase. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: JSPS KAKENHI, Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Androgen receptor signaling inhibitors(ARSIs) have been used to treat patients with metastatic prostate cancer (PC) and castration‐resistant prostate cancer (CRPC). In this study, we aimed to identify novel serum extracellular vesicle (EV)‐based biomarkers to diagnose ARSI‐resistance and therapeutic targets for ARSI‐resistant CRPC.

Methods

Total RNA contained in serum EVs from 5 cases of CRPC before ARSI treatment and after acquiring ARSI‐resistance was subjected to RNA‐sequencing. The expression changes of selected RNAs contained in EVs were confirmed in 48 cases of benign prostatic hyperplasia (BPH) and 107 PC using reverse transcription‐quantitative PCR (RT‐qPCR) and compared with tissue RNA expression using public datasets.

Results

RNA‐sequencing revealed that mitochondrial oxidative phosphorylation (OXPHOS)‐related genes were increased in EVs after acquiring ARSI‐resistance. Among them, RT‐qPCR and datasets analysis demonstrated that SDHB mRNA was upregulated after acquiring ARSI‐resistance in EVs and ARSI‐exposed PC tissue compared to ARSI‐naïve EVs and tissue, respectively. SDHB mRNA levels both in EVs and tissue were increased in localized PC compared with BPH and decreased in advanced PC. Tissue expression of SDHB mRNA was significantly correlated with those of other OXPHOS‐related genes. SDHB mRNA in EVs (EV‐ SDHB ) was elevated among 3 out of 7 ARSI‐treating patients with stable PSA levels who later progressed to ARSI‐resistant CRPC.

Conclusions

The levels of OXPHOS‐related mRNAs in EVs correlated with those in PC tissue, among which SDHB mRNA was found to be a novel biomarker to diagnose ARSI‐resistance. EV‐ SDHB may be useful for early diagnosis of ARSI‐resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesRNA, MessengerProstatic Neoplasms, Castration-ResistantSuccinate DehydrogenaseBiomarkers, TumorHumansMaleAgedMiddle AgedProstatic NeoplasmsReceptors, AndrogenDrug Resistance, NeoplasmProstatic HyperplasiaAndrogen Antagonists

Stichwörter der Autor:innen

CRPCSDHBandrogen signaling inhibitorsextracellular vesicles

Substanzen

RNA, MessengerSDHB protein, humanSuccinate DehydrogenaseBiomarkers, TumorReceptors, AndrogenAndrogen Antagonists

Autor:innen und Institutionen

  • Department of Joint Research Laboratory of Clinical Medicine, Fujita Health University School of Medicine, Toyoake, Japan.
  • Department of Urology, Asahi University Hospital, Gifu, Japan.
  • Open Facility Center, Fujita Health University School of Medicine, Toyoake, Japan.
  • Research Team for Functional Biogerontology, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
  • Molecular and Cellular Aging, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan.
  • Department of Urology, Central Japan International Medical Center, Gifu, Japan.

ORCID-Profile: Taku Kato

Förderung

  • JSPS KAKENHI
  • Japan Society for the Promotion of Science

Zitieren

APA

Kato, T., Sugihara, E., Hata, Y., Kawakami, K., Fujita, Y., Mizutani, K., Ando, T., Sakai, Y., Sakurai, K., Toyota, S., Ehara, H., Ito, M., & Ito, H. (2024). Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer. The Prostate. https://doi.org/10.1002/pros.24792

Vancouver

Kato T, Sugihara E, Hata Y, Kawakami K, Fujita Y, Mizutani K, et al. Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer. The Prostate. 2024. doi:10.1002/pros.24792

BibTeX
@article{Kato2024,
  author = {Kato, Taku and Sugihara, Eiji and Hata, Yuko and Kawakami, Kyojiro and Fujita, Yasunori and Mizutani, Kosuke and Ando, Tatsuya and Sakai, Yasuhiro and Sakurai, Kouhei and Toyota, Shohei and Ehara, Hidetoshi and Ito, Masafumi and Ito, Hiroyasu},
  title = {Diagnostic potential of SDHB mRNA contained in serum extracellular vesicles among patients with prostate cancer},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24792}
}
Kostenlos starten →